These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 25964117)

  • 1. Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis.
    Wang X; Xie G; Zhao A; Zheng X; Huang F; Wang Y; Yao C; Jia W; Liu P
    J Proteome Res; 2016 Apr; 15(4):1126-34. PubMed ID: 25964117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary metabolite variation is associated with pathological progression of the post-hepatitis B cirrhosis patients.
    Wang X; Wang X; Xie G; Zhou M; Yu H; Lin Y; Du G; Luo G; Jia W; Liu P
    J Proteome Res; 2012 Jul; 11(7):3838-47. PubMed ID: 22624806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: evidence from a human metabolomic study and in vitro experiments.
    Liu Z; Zhang Z; Huang M; Sun X; Liu B; Guo Q; Chang Q; Duan Z
    BMC Gastroenterol; 2018 Jul; 18(1):112. PubMed ID: 29996772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of Bile Acids in Diagnosing Hepatitis C Virus-Induced Liver Cirrhosis and Hepatocellular Carcinoma.
    Khalil A; ElSheashaey A; Abdelsameea E; Obada M; Bayomy F F M; El-Said H
    Br J Biomed Sci; 2022; 79():10191. PubMed ID: 35996509
    [No Abstract]   [Full Text] [Related]  

  • 5. [Characteristics and diagnostic value of serum bile acids profile in pregnant women with intrahepatic cholestasis of pregnancy and asymptomatic hypercholanemia of pregnancy].
    Gou LS; Yin X; Liu J; Suo F; Wu XY; Wang ZZ; Wang QL; Dong BL; Gu MS; Liu DY
    Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):270-278. PubMed ID: 38644273
    [No Abstract]   [Full Text] [Related]  

  • 6. Gas chromatography/mass spectrometry screening of serum metabolomic biomarkers in hepatitis B virus infected cirrhosis patients.
    Xue R; Dong L; Wu H; Liu T; Wang J; Shen X
    Clin Chem Lab Med; 2009; 47(3):305-10. PubMed ID: 19676142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A serum metabonomic study on the difference between alcohol- and HBV-induced liver cirrhosis by ultraperformance liquid chromatography coupled to mass spectrometry plus quadrupole time-of-flight mass spectrometry.
    Lian JS; Liu W; Hao SR; Guo YZ; Huang HJ; Chen DY; Xie Q; Pan XP; Xu W; Yuan WX; Li LJ; Huang JR
    Chin Med J (Engl); 2011 May; 124(9):1367-73. PubMed ID: 21740750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin and magnetic resonance imaging-liver volume to identify hepatitis B-related cirrhosis and esophageal varices.
    Li H; Chen TW; Li ZL; Zhang XM; Li CJ; Chen XL; Chen GW; Hu JN; Ye YQ
    World J Gastroenterol; 2015 Jan; 21(3):988-96. PubMed ID: 25624735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjugated bile acids in gallbladder bile and serum as potential biomarkers for cholesterol polyps and adenomatous polyps.
    Zhao MF; Huang P; Ge CL; Sun T; Ma ZG; Ye FF
    Int J Biol Markers; 2016 Feb; 31(1):e73-9. PubMed ID: 26541419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of individual serum bile acids in chronic liver diseases: fasting levels and results of oral chenodeoxycholic acid tolerance test.
    Adachi Y; Nanno T; Itoh T; Kurumi Y; Yamazaki K; Sawada Y; Yamamoto T
    Gastroenterol Jpn; 1988 Aug; 23(4):401-7. PubMed ID: 3181666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of serum bile acids as metabolite biomarkers for liver cirrhosis: a systematic review and meta-analysis.
    Han X; Wang J; Gu H; Guo H; Cai Y; Liao X; Jiang M
    Metabolomics; 2022 Jun; 18(7):43. PubMed ID: 35759044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of individual serum bile acids in patients with liver diseases using high-performance liquid chromatography.
    Okuda H; Obata H; Nakanishi T; Hisamitsu T; Matsubara K; Watanabe H
    Hepatogastroenterology; 1984 Aug; 31(4):168-71. PubMed ID: 6479837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum bile acid concentrations in mild liver cirrhosis.
    Greco AV; Mingrone G
    Clin Chim Acta; 1993 Nov; 221(1-2):183-9. PubMed ID: 8149635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced cortisol in the absence of bacterial infection in patients with hepatitis B virus cirrhosis.
    Zhang J; Yu HW; Li J; Zhu YK; Wang KF; Jia L; Meng QH
    Genet Mol Res; 2015 Jul; 14(3):7957-63. PubMed ID: 26214477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolite variations between acute-on-chronic liver failure and chronic liver failure caused by hepatitis B virus based on ultra-performance liquid chromatography mass spectrometry.
    Lian J; Li X; Wang Y; Yang J; Liu W; Ma J; Chen D; Li L; Huang J
    Biomed Pharmacother; 2016 Dec; 84():994-1000. PubMed ID: 27768929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical diagnostic significance of prealbumin, cholinesterase and retinol binding protein in liver cirrhosis combined with encephalopathy.
    Tan L; Meng Y; Zeng T; Wang Q; Long T; Wu S; Guan X; Fu H; Zheng W; Tian Y; Chen J; Yu J; Wu Y; Li H; Cao L
    Br J Biomed Sci; 2019 Jan; 76(1):24-28. PubMed ID: 30392460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child-Pugh score and serum bile acid levels.
    Festi D; Capodicasa S; Sandri L; Colaiocco-Ferrante L; Staniscia T; Vitacolonna E; Vestito A; Simoni P; Mazzella G; Portincasa P; Roda E; Colecchia A
    World J Gastroenterol; 2005 Jan; 11(1):142-8. PubMed ID: 15609414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolite profiling analysis of hepatitis B virus-induced liver cirrhosis patients with minimal hepatic encephalopathy using gas chromatography-time-of-flight mass spectrometry and ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry.
    Huang G; Xie S; Wang M; Mao D; Huang G; Huang J; Liu X; Zhang R; Xie J; Huang LJ; Cheng C; Yao F; Zhong Y; Lin L; Yao C
    Biomed Chromatogr; 2023 Jan; 37(1):e5529. PubMed ID: 36250932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum transforming growth factor-beta1(TGF-beta1) in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C [corrected].
    Kirmaz C; Terzioglu E; Topalak O; Bayrak P; Yilmaz O; Ersoz G; Sebik F
    Eur Cytokine Netw; 2004; 15(2):112-6. PubMed ID: 15319169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients.
    Arain SQ; Talpur FN; Channa NA; Ali MS; Afridi HI
    Lipids Health Dis; 2017 Mar; 16(1):51. PubMed ID: 28249586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.